Related Experiment Videos
The pharmacology of Parkinson's disease therapy: an update
1National Institutes of Health, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland 20892.
Annual Review of Pharmacology and Toxicology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.
The Journal of clinical endocrinology and metabolism·1995
Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Journal of neurochemistry·1995
Norepinephrine metabolism and psychoactive drugs in the endogenous depressions. 1968.
Pharmacopsychiatry·1995
Effects of hypercortisolemia or hyperinsulinemia on neurochemical indices of catecholamine release and synthesis in conscious rats.
Journal of the autonomic nervous system·1995
Protein Synthesis Dysregulation in Neurodegeneration: Mechanisms, Consequences, and Therapeutic Modulation.
Annual review of pharmacology and toxicology·2026
Precision Drug Discovery in the Era of Artificial Intelligence: A Critical Review.
Annual review of pharmacology and toxicology·2026
New Natural Product Antibiotics: Strategies and Tools That Offer New Approaches to Overcome Traditional Roadblocks.
Annual review of pharmacology and toxicology·2026
Making Drug Dosing Decisions Based on Therapeutic Monitoring.
Annual review of pharmacology and toxicology·2026
Pharmacoexposomics: The Environmental Complement to Pharmacogenomics to Advance Precision Medicine.
Annual review of pharmacology and toxicology·2026
Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad.
Annual review of pharmacology and toxicology·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026